A detailed history of State Of Alaska, Department Of Revenue transactions in Pfizer Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 836,141 shares of PFE stock, worth $21.6 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
836,141
Previous 843,641 0.89%
Holding current value
$21.6 Million
Previous $23.6 Million 2.51%
% of portfolio
0.26%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$27.7 - $31.39 $207,750 - $235,425
-7,500 Reduced 0.89%
836,141 $24.2 Million
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $455,437 - $533,688
-18,030 Reduced 2.09%
843,641 $23.6 Million
Q1 2024

Apr 19, 2024

SELL
$25.89 - $29.73 $872,751 - $1 Million
-33,710 Reduced 3.76%
861,671 $23.9 Million
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $1.48 Million - $1.92 Million
-56,605 Reduced 5.95%
895,381 $25.8 Million
Q3 2023

Oct 16, 2023

SELL
$32.09 - $37.51 $847,176 - $990,264
-26,400 Reduced 2.7%
951,986 $31.6 Million
Q2 2023

Jul 24, 2023

SELL
$36.12 - $41.79 $5.08 Million - $5.88 Million
-140,711 Reduced 12.57%
978,386 $35.9 Million
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $375,859 - $489,313
-9,542 Reduced 0.85%
1,119,097 $45.7 Million
Q4 2022

Jan 11, 2023

BUY
$41.75 - $54.5 $285,778 - $373,052
6,845 Added 0.61%
1,128,639 $57.8 Million
Q3 2022

Oct 20, 2022

SELL
$43.76 - $53.42 $1.89 Million - $2.31 Million
-43,171 Reduced 3.71%
1,121,794 $49.1 Million
Q2 2022

Jul 08, 2022

BUY
$46.53 - $55.17 $5 Million - $5.93 Million
107,476 Added 10.16%
1,164,965 $61.1 Million
Q1 2022

Apr 14, 2022

SELL
$45.75 - $56.69 $1.19 Million - $1.47 Million
-25,964 Reduced 2.4%
1,057,489 $54.7 Million
Q4 2021

Jan 12, 2022

BUY
$41.32 - $61.25 $1.16 Million - $1.72 Million
28,101 Added 2.66%
1,083,453 $64 Million
Q3 2021

Oct 07, 2021

SELL
$39.25 - $50.42 $628,196 - $806,972
-16,005 Reduced 1.49%
1,055,352 $45.4 Million
Q2 2021

Jul 12, 2021

BUY
$35.91 - $40.68 $848,158 - $960,820
23,619 Added 2.25%
1,071,357 $42 Million
Q1 2021

Apr 09, 2021

SELL
$33.49 - $37.77 $1.47 Million - $1.66 Million
-43,951 Reduced 4.03%
1,047,738 $38 Million
Q4 2020

Jan 08, 2021

SELL
$33.47 - $42.56 $2.02 Million - $2.57 Million
-60,499 Reduced 5.25%
1,091,689 $40.2 Million
Q3 2020

Oct 05, 2020

BUY
$31.75 - $37.25 $696,118 - $816,706
21,925 Added 1.94%
1,152,188 $42.3 Million
Q2 2020

Jul 06, 2020

BUY
$30.12 - $36.54 $2.57 Million - $3.11 Million
85,235 Added 8.16%
1,130,263 $37 Million
Q1 2020

Apr 06, 2020

BUY
$27.03 - $38.62 $1.47 Million - $2.1 Million
54,336 Added 5.48%
1,045,028 $34.1 Million
Q4 2019

Jan 07, 2020

SELL
$32.92 - $37.36 $4.56 Million - $5.18 Million
-138,566 Reduced 12.27%
990,692 $38.8 Million
Q3 2019

Oct 02, 2019

SELL
$32.49 - $42.13 $7.76 Million - $10.1 Million
-238,745 Reduced 17.45%
1,129,258 $40.6 Million
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $392,616 - $440,817
10,617 Added 0.78%
1,368,003 $59.3 Million
Q1 2019

Apr 09, 2019

SELL
$37.5 - $41.2 $1.92 Million - $2.11 Million
-51,276 Reduced 3.64%
1,357,386 $57.6 Million
Q4 2018

Jan 10, 2019

SELL
$38.47 - $43.86 $70,707 - $80,614
-1,838 Reduced 0.13%
1,408,662 $61.5 Million
Q3 2018

Oct 09, 2018

SELL
$34.47 - $41.81 $2.69 Million - $3.27 Million
-78,115 Reduced 5.25%
1,410,500 $62.2 Million
Q2 2018

Jul 10, 2018

BUY
$32.98 - $35.16 $5.49 Million - $5.86 Million
166,546 Added 12.6%
1,488,615 $54 Million
Q1 2018

Apr 19, 2018

BUY
$31.91 - $37.02 $2.67 Million - $3.1 Million
83,650 Added 6.75%
1,322,069 $46.9 Million
Q4 2017

Jan 19, 2018

BUY
$33.26 - $35.29 $17 Million - $18.1 Million
512,311 Added 70.56%
1,238,419 $44.9 Million
Q3 2017

Oct 16, 2017

BUY
$31.0 - $34.15 $22.5 Million - $24.8 Million
726,108
726,108 $25.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.